Cargando…
Pathobiology of Cutaneous Manifestations Associated with COVID-19 and Their Management
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19) has been a rising concern since its declaration as a pandemic by the World Health Organization on 11 March 2020. Recently, its association with multiple underlying organs has been identified that...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500986/ https://www.ncbi.nlm.nih.gov/pubmed/36146777 http://dx.doi.org/10.3390/v14091972 |
_version_ | 1784795359067766784 |
---|---|
author | Masood, Waniyah Ahmad, Shahzaib Khan, Noor Ayman Shakir, Amaima Rokni, Ghasem Rahmatpour Gold, Michael H. Cockerell, Clay J. Schwartz, Robert A. Goldust, Mohamad |
author_facet | Masood, Waniyah Ahmad, Shahzaib Khan, Noor Ayman Shakir, Amaima Rokni, Ghasem Rahmatpour Gold, Michael H. Cockerell, Clay J. Schwartz, Robert A. Goldust, Mohamad |
author_sort | Masood, Waniyah |
collection | PubMed |
description | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19) has been a rising concern since its declaration as a pandemic by the World Health Organization on 11 March 2020. Recently, its association with multiple underlying organs has been identified that includes cardiac, renal, gastrointestinal, nervous systems, and cutaneous manifestations. Cutaneous COVID-19 findings have been supposedly classified into the following categories: vesicular (varicella-like), papulo-vesiculsar, chilblains-like (“COVID toes”) maculopapular, and urticarial morphologies. In this review, we aim to focus on the proposed pathophysiology behind the various dermatological manifestations associated with COVID-19 and their associated management. We also included prevalence and clinical features of the different COVID-19-related skin lesions in our review. A comprehensive narrative review of the literature was performed in PubMed databases. Data from case reports, observational studies, case series, and reviews till June 2022 were all screened and included in the review. |
format | Online Article Text |
id | pubmed-9500986 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95009862022-09-24 Pathobiology of Cutaneous Manifestations Associated with COVID-19 and Their Management Masood, Waniyah Ahmad, Shahzaib Khan, Noor Ayman Shakir, Amaima Rokni, Ghasem Rahmatpour Gold, Michael H. Cockerell, Clay J. Schwartz, Robert A. Goldust, Mohamad Viruses Review Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19) has been a rising concern since its declaration as a pandemic by the World Health Organization on 11 March 2020. Recently, its association with multiple underlying organs has been identified that includes cardiac, renal, gastrointestinal, nervous systems, and cutaneous manifestations. Cutaneous COVID-19 findings have been supposedly classified into the following categories: vesicular (varicella-like), papulo-vesiculsar, chilblains-like (“COVID toes”) maculopapular, and urticarial morphologies. In this review, we aim to focus on the proposed pathophysiology behind the various dermatological manifestations associated with COVID-19 and their associated management. We also included prevalence and clinical features of the different COVID-19-related skin lesions in our review. A comprehensive narrative review of the literature was performed in PubMed databases. Data from case reports, observational studies, case series, and reviews till June 2022 were all screened and included in the review. MDPI 2022-09-06 /pmc/articles/PMC9500986/ /pubmed/36146777 http://dx.doi.org/10.3390/v14091972 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Masood, Waniyah Ahmad, Shahzaib Khan, Noor Ayman Shakir, Amaima Rokni, Ghasem Rahmatpour Gold, Michael H. Cockerell, Clay J. Schwartz, Robert A. Goldust, Mohamad Pathobiology of Cutaneous Manifestations Associated with COVID-19 and Their Management |
title | Pathobiology of Cutaneous Manifestations Associated with COVID-19 and Their Management |
title_full | Pathobiology of Cutaneous Manifestations Associated with COVID-19 and Their Management |
title_fullStr | Pathobiology of Cutaneous Manifestations Associated with COVID-19 and Their Management |
title_full_unstemmed | Pathobiology of Cutaneous Manifestations Associated with COVID-19 and Their Management |
title_short | Pathobiology of Cutaneous Manifestations Associated with COVID-19 and Their Management |
title_sort | pathobiology of cutaneous manifestations associated with covid-19 and their management |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500986/ https://www.ncbi.nlm.nih.gov/pubmed/36146777 http://dx.doi.org/10.3390/v14091972 |
work_keys_str_mv | AT masoodwaniyah pathobiologyofcutaneousmanifestationsassociatedwithcovid19andtheirmanagement AT ahmadshahzaib pathobiologyofcutaneousmanifestationsassociatedwithcovid19andtheirmanagement AT khannoorayman pathobiologyofcutaneousmanifestationsassociatedwithcovid19andtheirmanagement AT shakiramaima pathobiologyofcutaneousmanifestationsassociatedwithcovid19andtheirmanagement AT roknighasemrahmatpour pathobiologyofcutaneousmanifestationsassociatedwithcovid19andtheirmanagement AT goldmichaelh pathobiologyofcutaneousmanifestationsassociatedwithcovid19andtheirmanagement AT cockerellclayj pathobiologyofcutaneousmanifestationsassociatedwithcovid19andtheirmanagement AT schwartzroberta pathobiologyofcutaneousmanifestationsassociatedwithcovid19andtheirmanagement AT goldustmohamad pathobiologyofcutaneousmanifestationsassociatedwithcovid19andtheirmanagement |